Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Exploring heterogeneous treatment effects for GLP-1 receptor agonists in patients with type 2 diabetes
American journal of epidemiology, 2026
Safety outcomes of semaglutide by chronic kidney disease severity in the FLOW trial
Kidney international, 2026
Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury
Cell reports. Medicine, 2026;:103115
Adverse oral effects of GLP-1 and GIP receptor agonists: a scoping review protocol
BMJ open, 2026;16(10):e122207
Tirzepatide-Associated Lithium Toxicity: A Case Report
Journal of clinical psychopharmacology, 2026
Real-world observational study evaluating metabolic and kidney outcomes in patients living with chronic kidney disease and type 2 diabetes mellitus with obesity prescribed tirzepatide
Diabetic medicine : a journal of the British Diabetic Association, 2026;:e70500
Real-World Semaglutide Initiation Behaviours in the United States: Impact on Early Treatment Discontinuation and on 1-Year Persistence
Diabetes, obesity & metabolism, 2026
Changes in Muscle Strength Following Semaglutide Treatment in Adults: A Systematic Review With Meta-Analysis of Handgrip Strength
Diabetes, obesity & metabolism, 2026
Mechanistic benchmarking of SNAC, DDM, and LLC reveals enhancer-dependent pathways for intestinal semaglutide delivery
Journal of controlled release : official journal of the Controlled Release Society, 2026;:115455
Diabetic Retinal Disease Onset and Progression During Established Semaglutide or Tirzepatide Treatment: A Retrospective Comparative Cohort Study With a Descriptive Regional Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Review
Cureus, 2026;18(10):e118195
Tirzepatide Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension: Association with the SIRT1/H4K12la/c-Jun Axis
Cells, 2026;15(20)
Incretin-based therapies in menopause: Current landscape
Maturitas, 2026;215:109159
[Changes in retinal light sensitivity and morphometry during surgical treatment of primary glaucoma with physiotherapeutic stimulation]
Vestnik oftalmologii;142(5):48-55
GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes
International journal of molecular sciences, 2026;27(20)
GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study
International journal of cardiology, 2026;:135000
Economic evaluation of tirzepatide, semaglutide, and liraglutide in the treatment of obese and overweight patients without diabetes: a short-term cost-effectiveness analysis in Iran
Journal of diabetes and metabolic disorders, 2026;25(2):292
Recurrent In-Stent Restenosis and Accelerated Neoatherosclerosis in a Middle-Aged Woman With High Inflammatory Burden
JACC. Case reports, 2026;:110991
Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity
Journal of the American Heart Association, 2026;:e051982
Qualitative Exit Interviews to Characterize the Positive Treatment Experiences of Patients in the Phase III Trial of Orforglipron Versus Oral Semaglutide for the Treatment of Type 2 Diabetes
The patient, 2026
Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women
Nature medicine, 2026